Clinical Trial Update: A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of JMT108 in advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• JMT108

Snippet

Sponsor: Conjupro Biotherapeutics, Inc. | Conditions: Cancer, Cancer (Solid Tumors) | Phase 1 | Status: RECRUITING